Innoviva (INVA) Total Debt (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.14% |
| Dec 31, 2025 | 0.14% |
| Sep 30, 2025 | -42.67% |
| Jun 30, 2025 | 0.01% |
| Mar 31, 2025 | 0.12% |
| Dec 31, 2024 | 0.12% |
| Sep 30, 2024 | 0.12% |
| Jun 30, 2024 | 0.12% |
| Mar 31, 2024 | 0.12% |
| Dec 31, 2023 | 0.12% |
| Sep 30, 2023 | 0.12% |
| Jun 30, 2023 | 0.11% |
| Mar 31, 2023 | -17.71% |
| Dec 31, 2022 | 0.10% |
| Sep 30, 2022 | 461.88% |
| Jun 30, 2022 | 0.06% |
| Mar 31, 2022 | -75.67% |
| Dec 31, 2021 | 0.60% |
| Sep 30, 2021 | 0.59% |
| Jun 30, 2021 | 0.58% |
| Mar 31, 2021 | 0.57% |
| Dec 31, 2020 | 0.57% |
| Sep 30, 2020 | 0.56% |
| Jun 30, 2020 | 0.55% |
| Mar 31, 2020 | 0.54% |
| Dec 31, 2019 | -2.97% |
| Sep 30, 2019 | 0.51% |
| Jun 30, 2019 | 0.50% |
| Mar 31, 2019 | 0.49% |
| Dec 31, 2018 | 0.49% |
| Sep 30, 2018 | -21.69% |
| Jun 30, 2018 | 0.40% |
| Mar 31, 2018 | -19.15% |
| Dec 31, 2017 | -0.68% |
| Sep 30, 2017 | 45.05% |
| Jun 30, 2017 | -11.73% |
| Mar 31, 2017 | -34.18% |
| Dec 31, 2016 | 48.73% |
| Sep 30, 2016 | -0.55% |
| Jun 30, 2016 | 0.16% |
| Mar 31, 2016 | 0.26% |
| Dec 31, 2015 | -1.40% |
| Sep 30, 2015 | 1.16% |
| Jun 30, 2015 | 1.34% |
| Mar 31, 2015 | 1.14% |
| Dec 31, 2014 | 2.52% |
| Sep 30, 2014 | 2.22% |
| Mar 31, 2012 | -81.16% |
| Dec 31, 2011 | -36.70% |
| Sep 30, 2011 | -32.72% |